Best realization ever (up 7% qoq) led to 14.4% yoy topline growth.
OPM stood at 21.6%, flat on yoy basis as higher fuel and freight cost neutralize benefit arising on account of higher realization.
PAT grew 26.1% on back of higher other income.
Upgrade from SELL rating to Reduce with a revised 9-month price target of Rs209
|(Rs mn)||Q2 CY14||Q2 CY13||% yoy||Q1 CY14||% qoq|
|Power and fuel costs||6,242||5,560||12.3||5,783||7.9|
|OPM (%)||21.6||22.0||(39 bps)||22.2||(61 bps)|
|Effective tax rate (%)||29.7||29.2||10.8|
|Adj. PAT margin (%)||15.0||13.6||139 bps||19.6||(459 bps)|
Best ever realizations boost revenues
Ambuja Cements (ACL) revenues stood at Rs27.2bn, above our estimate of Rs26bn. The outperformance was largely due to higher realization up 7% sequentially against expectations of 3%qoq. Realizations have improved ~18% over the past two quarters translating into best ever realization for ACL. We believe better pricing trend especially in western and northern regions led to a jump in realizations. Volume growth of 8%yoy was in-line with estimates.
|As a % of net sales||Q2 CY14||Q2 CY13||bps yoy||Q1 CY14||bps qoq|
|Power and fuel costs||22.9||23.4||(45)||21.8||113|
Margins flat as power and freight cost mitigate benefit of higher realizations
Operating margins for ACL remained flat despite of a 7%qoq jump in realization. OPM was lower on back of a) increase in power and fuel cost, which stood at Rs1,078/ton at 6 quarter high and b) surge in railway freight and diesel prices impact the cost overhead (Rs1,192/ton as against Rs1,088/ton qoq basis) arrested any expansion on operational front.
Other income was higher on back of inclusion of interest on income tax pertaining to previous year. PAT grew 26%yoy, primarily on account of Rs500mn additional other income.
Expensive valuations; Upgrade to reduce
Government emphasis on a) housing for all, b) 100 new cities, and c) infrastructure development like building ports and roads is most likely to boost cement demand in the coming years. Construction activity is most likely to pick up in northern and western markets, impacting volume and realization of companies like ACL. Though we continue to believe ACL is trading at an expensive valuation, we upgrade the stock to reduce from SELL on back of rolling over our valuation to CY16 from CY15 in the previous quarter.
|Y/e 31 Mar (Rs m)||CY13||CY14E||CY15E||CY16E|
|Yoy growth (%)||(5.9)||18.3||11.1||10.8|
|Yoy growth (%)||(0.2)||12.4||18.1||23.8|